The invention relates to compounds of formula (I):
or a salt thereof, wherein R
1
, A, L, and R
2
and n are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are αvβ1 integrin inhibitors that are useful for treating tissue specific fibrosis.